Citation: N. Block, IS EXPERIENCING JUST REPRESENTING (ON TYE,MICHAEL 'TEN PROBLEMS OF CONSCIOUSNESS'), Philosophy and phenomenological research, 58(3), 1998, pp. 663-670
Authors:
LOKESHWAR V
YOUNG M
WEI D
BRADY J
SOLOWAY M
BLOCK N
Citation: V. Lokeshwar et al., HA-HASE TEST - A TEST FOR DETECTING BLADDER-CANCER AND MONITORING TUMOR RECURRENCE, The Journal of urology, 159(5), 1998, pp. 923-923
Authors:
ANDRIOLE GL
DENIS L
BLACKLEDGE G
SCHMIDT J
SAGALOWSKY A
IVERSEN P
SOLOWAY M
FURR B
BLOCK N
BANERJEE T
YOUNG J
KOLVENBAG GCM
OESTERLING JE
NIEH PTC
MONTIE JE
SCHELLHAMMER PF
BALES GT
KLEIN EA
BROSMAN S
Citation: Gl. Andriole et al., CLINICAL-TRIALS OF BICALUTAMIDE AS MONOTHERAPY FOR PROSTATE-CANCER - DISCUSSION, Urology, 47(1A), 1996, pp. 48-53
Authors:
SCHELLHAMMER P
SHARIFI R
BLOCK N
SOLOWAY M
VENNER P
PATTERSON AL
SAROSDY M
VOGELZANG N
JONES J
KOLVENBAG G
Citation: P. Schellhammer et al., MAXIMAL ANDROGEN BLOCKADE FOR PATIENTS WITH METASTATIC PROSTATE-CANCER - OUTCOME OF A CONTROLLED TRIAL OF BICALUTAMIDE VERSUS FLUTAMIDE, EACH IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONEANALOGUE THERAPY, Urology, 47(1A), 1996, pp. 54-60
Authors:
RICHIE JP
SCHELLHAMMER PF
SCHER H
HAAS G
PATTERSON K
SAGALOWSKY A
KOLVENBAG GJCM
KENNEALEY G
IVERSEN P
BROSMAN S
KLEIN EA
FURR B
BLOCK N
DENIS L
SCHMIDT J
SOLOWAY M
OESTERLING JE
YOUNG J
Citation: Jp. Richie et al., CLINICAL-DATA ON THE ROLE OF BICALUTAMIDE IN METASTATIC PROSTATE-CANCER - DISCUSSION, Urology, 47(1A), 1996, pp. 80-84
Authors:
OESTERLING JE
MCLEOD DG
RICHIE JP
MALKOWICZ SB
ANDRIOLE GL
SEIDMON J
KOLVENBAG GJCM
BLACKLEDGE G
SCHMIDT J
KLEIN EA
SOLOWAY M
MONTIE JE
GOMELLA L
HAAS G
SCHER H
RAMSEY EW
BROSMAN S
LYNCH D
WAJSMAN Z
BABAIAN R
ROMAS N
BLOCK N
Citation: Je. Oesterling et al., THE EXPECTED VALUE OF BICALUTAMIDE IN THE MANAGEMENT OF PROSTATIC DISEASE - DISCUSSION, Urology, 47(1A), 1996, pp. 90-96
Authors:
SCHELLHAMMER P
SHARIFI R
BLOCK N
SOLOWAY M
VENNER P
PATTERSON AL
SAROSDY M
VOGELZANG N
JONES J
KOLVENBAG G
Citation: P. Schellhammer et al., A CONTROLLED TRIAL OF BICALUTAMIDE VERSUS FLUTAMIDE, EACH IN COMBINATION WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG THERAPY, IN PATIENTS WITH ADVANCED PROSTATE-CANCER, Urology, 45(5), 1995, pp. 745-752
Authors:
ANDRIOLE G
LIEBER M
SMITH J
SOLOWAY M
SCHROEDER F
KADMON D
DEKERNION J
RAJFER J
BOAKE R
CRAWFORD D
RAMSEY E
PERREAULT J
TRACHTENBERG J
FRADET T
BLOCK N
MIDDLETON R
NG J
FERGUSON D
GORMLEY G
Citation: G. Andriole et al., TREATMENT WITH FINASTERIDE FOLLOWING RADICAL PROSTATECTOMY FOR PROSTATE-CANCER, Urology, 45(3), 1995, pp. 491-497
Authors:
BERGER BM
NAADIMUTKU A
BODDY A
FISHER HA
MCCONNELL JD
MILAM D
MOBLEY D
RAJFER J
ADAMS G
AIGEN AB
BOYD S
NARAYAN P
ANDRIOLE G
BAHNSON R
BELVILLE W
TOPLEY HM
BLOCK N
EPSTEIN HB
LAZAN DW
BAKULE PT
BOYLE ET
FERRIGNI R
BRANNAN W
BRAWER MK
FOSS F
COX CE
SMITH J
ELHILALI M
GOLDENBERG L
SULLIVAN L
NORMAN R
LAWEN JG
TRACHTENBERG J
LEPOR H
KANDZARI S
LABASKY R
KALISH M
PICKETT SH
Citation: Bm. Berger et al., THE EFFECT OF ZANOTERONE, A STEROIDAL ANDROGEN RECEPTOR ANTAGONIST, IN MEN WITH BENIGN PROSTATIC HYPERPLASIA, The Journal of urology, 154(3), 1995, pp. 1060-1064
Authors:
CHESS B
MOGASSA M
ENRIQUEZ E
SYLBER M
VILLALVAZO M
GHEBREMEDHIN A
HOU G
BLOCK N
MILLER J
SHARP SB
Citation: B. Chess et al., HERCULIN TRANSGENE EXPRESSION IN MYOGENIC BC3H1 CELLS MAY INCREASE ENDOGENOUS HERCULIN GENE-EXPRESSION WITHOUT AFFECTING MYOD1 OR VASCULAR SMOOTH-MUSCLE ACTIN MESSENGER-RNA LEVELS, The FASEB journal, 7(7), 1993, pp. 1223-1223